Literature DB >> 1418700

Neuropsychiatric reactions to nonsteroidal anti-inflammatory drugs (NSAIDs). The New Zealand experience.

D W Clark1, K Ghose.   

Abstract

The New Zealand Medicines Adverse Reactions Committee has been monitoring reports of adverse drug reactions (ADRs) since 1965. We wished to determine the numbers of voluntary reports of different types of ADR to all nonsteroidal anti-inflammatory drugs (NSAIDs) over a long time period and relate these to age. As the elderly are known to suffer from neuropsychiatric adverse effects of many drugs, we investigated neuropsychiatric reactions to NSAIDs to determine whether these were more commonly reported in the elderly. We counted all reported ADRs suspected to be associated with NSAIDs as well as selected types of ADRs reported from 1970 to 1989. These were divided into 5-year periods and 10-year age groupings. In each consecutive 5-year period there was a progressive increase in the numbers of all ADRs reported for all NSAIDs. This was particularly marked above 50 years of age, but the numbers were reduced above 80 years. Reports for females accounted for about two-thirds of all reactions. Not unexpectedly, alimentary and dermatological ADRs accounted for most reactions and were more common in the group above 50 years. Overall, neuropsychiatric reactions were the third most common ADR type reported. Their numbers increased with age and peaked in the 50 to 59 age group, with a sharp decline after 69 years. This age distribution paralleled that for all ADRs to NSAIDs. Although neuropsychiatric reactions to NSAIDs were reported in all age groups, they were not reported more commonly in the elderly. This study suggests that neuropsychiatric reactions to NSAIDs may be more frequent than is commonly believed.

Mesh:

Substances:

Year:  1992        PMID: 1418700     DOI: 10.2165/00002018-199207060-00006

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  9 in total

1.  The need for a review journal of drug use and the elderly.

Authors:  K Ghose
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

2.  Paranoid psychosis with indomethacin.

Authors:  M W Carney
Journal:  Br Med J       Date:  1977-10-15

3.  Drug reactions. Medicines Adverse Reactions Committee: report for the two years ending March 1987.

Authors:  I R Edwards; M G Beasley; D M Coulter
Journal:  N Z Med J       Date:  1988-12-14

4.  New Zealand Committee on Adverse Drug Reactions: thirteenth annual report 1978.

Authors:  E G McQueen
Journal:  N Z Med J       Date:  1979-02-28

Review 5.  Side-effects of non-steroidal anti-inflammatory drugs.

Authors:  D A Henry
Journal:  Baillieres Clin Rheumatol       Date:  1988-08

6.  Delirium associated with sulindac.

Authors:  T L Thornton
Journal:  JAMA       Date:  1980-04-25       Impact factor: 56.272

Review 7.  Aspirin, paracetamol and non-steroidal anti-inflammatory drugs. A comparative review of side effects.

Authors:  P D Fowler
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Sep-Oct

Review 8.  The problems and pitfalls of NSAID therapy in the elderly (Part I).

Authors:  A G Johnson; R O Day
Journal:  Drugs Aging       Date:  1991-03       Impact factor: 3.923

9.  Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly.

Authors:  K Beard; A M Walker; D R Perera; H Jick
Journal:  Arch Intern Med       Date:  1987-09
  9 in total
  3 in total

Review 1.  Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Authors:  Ruth Savage
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  NSAID-related psychiatric adverse events: who is at risk?

Authors:  Graziano Onder; Francesca Pellicciotti; Giovanni Gambassi; Roberto Bernabei
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  CNS Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs : Therapeutic Implications.

Authors:  A Morgan; D Clark
Journal:  CNS Drugs       Date:  1998-04       Impact factor: 5.749

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.